Andrej Alendar
Impact in
-
- Cancer Mechanisms and Therapy
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Chromatin Remodeling and Cancer 2
- Genomics and Chromatin Dynamics 2
- Cancer-related gene regulation 2
- Kruppel-like factors research 1
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Anton Berns (3 shared papers)Martijn C. Nawijn (1 shared paper)Tony Kouzarides (3 shared papers)Andrew J. Bannister (2 shared papers)Luca Pandolfini (2 shared papers)Valentina Migliori (1 shared paper)Pia Mach (1 shared paper)Byron Andrews (1 shared paper)
- Journals
- Genes & Development (1 paper)Nature reviews. Cancer (1 paper)Science Translational Medicine (1 paper)FEBS Letters (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- United KingdomNetherlandsItaly
In The Last Decade
Andrej Alendar
9 papers receiving 840 citations
Andrej Alendar's Hit Papers
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 331
- Cancer Research 259
- Molecular Biology 619
- Oncology 206
- Hematology 54
Countries citing papers authored by Andrej Alendar
This map shows the geographic impact of Andrej Alendar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Alendar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Alendar more than expected).
Fields of papers citing papers by Andrej Alendar
This network shows the impact of papers produced by Andrej Alendar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Alendar. The network helps show where Andrej Alendar may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrej Alendar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 378 | |
| 2 | METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation Hit paper breakdown → | 2019 | 349 |
| 3 | 2014 | 38 | |
| 4 | 2018 | 34 | |
| 5 | 2021 | 28 | |
| 6 | 2020 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2003 | 5 | |
| 9 | 2023 | 4 |
About Andrej Alendar
Andrej Alendar is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Oncology and Cellular and Molecular Neuroscience, having authored 9 papers that have together received 850 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers), Chromatin Remodeling and Cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), Cancer Mechanisms and Therapy (2 papers), Cancer-related gene regulation (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (331 citations), Cancer Research (259 citations), Molecular Biology (619 citations), Oncology (206 citations) and Hematology (54 citations). Andrej Alendar has collaborated with scholars based in United Kingdom, Netherlands and Italy. Frequent co-authors include Anton Berns, Martijn C. Nawijn, Tony Kouzarides, Andrew J. Bannister, Luca Pandolfini, Valentina Migliori, Pia Mach, Byron Andrews, Rossella Brandi and Pierre Murat. Their work appears in journals such as Genes & Development, Nature reviews. Cancer, Science Translational Medicine, FEBS Letters and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.